Biotech Capital Due Diligence Market Research 
Alpha Sense BI
APRIL 29, 2024
Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.
Alpha Sense BI
APRIL 19, 2024
On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. 2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e.
Expert insights. Personalized for you.
52 
Let's personalize your content